Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C et al. Arch Gen Psychiatry 2009; 66: 442–451.

    Article  CAS  PubMed  Google Scholar 

  2. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al. Lancet 2007; 370: 319–328.

    Article  PubMed  Google Scholar 

  3. Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD et al. Neuropsychopharmacology 2009; 34: 759–766.

    Article  CAS  PubMed  Google Scholar 

  4. Stokes PR, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A et al. Neuroimage 2010; 52: 1521–1527.

    Article  CAS  PubMed  Google Scholar 

  5. Stokes PR, Mehta MA, Curran HV, Breen G, Grasby PM . Neuroimage 2009; 48: 186–190.

    Article  PubMed  Google Scholar 

  6. Murray RM, Morrison PD, Henquet C, Di Forti M . Nat Rev Neurosci 2007; 8: 885–895.

    Article  CAS  PubMed  Google Scholar 

  7. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF . Proc Natl Acad Sci U S A 2009; 106: 617–622.

    Article  CAS  PubMed  Google Scholar 

  8. Beaulieu JM, Gainetdinov RR, Caron MG . Trends Pharmacol Sci 2007; 28: 166–172.

    CAS  PubMed  Google Scholar 

  9. Prata DP, Mechelli A, Picchioni MM, Fu CH, Toulopoulou T, Bramon E et al. Arch Gen Psychiatry 2009; 66: 1162–1172.

    Article  CAS  PubMed  Google Scholar 

  10. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al. Neuropsychopharmacology 2000; 22: 133–139.

    Article  CAS  PubMed  Google Scholar 

  11. van Winkel R . Arch Gen Psychiatry 2011; 68: 148–157.

    Article  CAS  PubMed  Google Scholar 

  12. Talkowski ME, Kirov G, Bamne M, Georgieva L, Torres G, Mansour H et al. Hum Mol Genet 2008; 17: 747–758.

    Article  CAS  PubMed  Google Scholar 

  13. Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R et al. J Clin Invest 2008; 118: 2200–2208.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA . Nat Genet 2004; 36: 131–137.

    CAS  PubMed  Google Scholar 

  15. Ozaita A, Puighermanal E, Maldonado R . J Neurochem 2007; 102: 1105–1114.

    Article  CAS  PubMed  Google Scholar 

  16. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H et al. Biol Psychiatry 2005; 57: 1117–1127.

    Article  CAS  PubMed  Google Scholar 

  17. Henquet C, Rosa A, Delespaul P, Papiol S, Fananas L, van Os J et al. Acta Psychiatr Scand 2009; 119: 156–160.

    Article  CAS  PubMed  Google Scholar 

  18. Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M et al. Neuropsychopharmacology 2006; 31: 2748–2757.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Dr Sagnik Bhattacharyya was supported by a Joint MRC/Priory Clinical research training fellowship from the Medical Research Council, UK. The authors also acknowledge financial support from Generalitat de Catalunya (SGR 2009/1435) and the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London, and the ongoing support of the Wellcome Trust and EPSRC toward the Medical Engineering Centre within King's College London.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Bhattacharyya.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhattacharyya, S., Atakan, Z., Martin-Santos, R. et al. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry 17, 1152–1155 (2012). https://doi.org/10.1038/mp.2011.187

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2011.187

This article is cited by

Search

Quick links